Form 8-K - Current report:
SEC Accession No. 0001571049-16-011076
Filing Date
2016-01-25
Accepted
2016-01-25 16:40:03
Documents
3
Period of Report
2016-01-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1600238_8k.htm 8-K 16032
2 EXHIBIT 99.1 t1600238_ex99-1.htm EX-99.1 6046
3 GRAPHIC logoex99-1.jpg GRAPHIC 14265
  Complete submission text file 0001571049-16-011076.txt   43214
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 161359162
SIC: 2834 Pharmaceutical Preparations